| 000 | 01755 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250515003212.0 | ||
| 264 | 0 | _c20051219 | |
| 008 | 200512s 0 0 ger d | ||
| 022 | _a0044-2771 | ||
| 024 | 7 |
_a10.1055/s-2005-858286 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHejna, M | |
| 245 | 0 | 0 |
_a[Neoadjuvant therapy for resectable esophageal cancer]. _h[electronic resource] |
| 260 |
_bZeitschrift fur Gastroenterologie _cOct 2005 |
||
| 300 |
_a1141-7 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntibiotics, Antineoplastic _xadministration & dosage |
| 650 | 0 | 4 |
_aAntimetabolites, Antineoplastic _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Phytogenic _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aBleomycin _xadministration & dosage |
| 650 | 0 | 4 |
_aCisplatin _xadministration & dosage |
| 650 | 0 | 4 | _aDose Fractionation, Radiation |
| 650 | 0 | 4 |
_aEsophageal Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aEtoposide _xadministration & dosage |
| 650 | 0 | 4 |
_aFluorouracil _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMeta-Analysis as Topic |
| 650 | 0 | 4 | _aNeoadjuvant Therapy |
| 650 | 0 | 4 | _aPostoperative Care |
| 650 | 0 | 4 | _aPreoperative Care |
| 650 | 0 | 4 | _aRadiotherapy Dosage |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aVindesine _xadministration & dosage |
| 700 | 1 | _aRaderer, M | |
| 773 | 0 |
_tZeitschrift fur Gastroenterologie _gvol. 43 _gno. 10 _gp. 1141-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1055/s-2005-858286 _zAvailable from publisher's website |
| 999 |
_c15849190 _d15849190 |
||